Generic Portal

— Research Explorer

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.1016/S1473-3099(22)00650-8
Final published version
https://doi.org/10.1016/S1473-3099(22)00650-8
Final published version

Marcia M. L. Kho
A. Lianne Messchendorp
Sophie C. Frölke
Celine Imhof
Vera Jch Koomen
S. Reshwan K. Malahe
Priya Vart
Daryl Geers
Rory D. de Vries
Corine H. GeurtsvanKessel
Carla C. Baan
Renate G. van der Molen
Dimitri A. Diavatopoulos
Ester B. M. Remmerswaal
Debbie van Baarle
Rob van Binnendijk
Gerco den Hartog
RECOVAC Collaborators
Aiko P. J. de Vries
Ron T. Gansevoort
Frederike J. Bemelman
Marlies E. J. Reinders
Jan-Stephan F. Sanders
Luuk B. Hilbrands

Original language	English
Pages (from-to)	307-319
Number of pages	13
Journal	Lancet infectious diseases
Volume	23
Issue number	3
DOIs	https://doi.org/10.1016/S1473-3099(22)00650-8 https://doi.org/10.1016/S1473-3099(22)00650-8
Publication status	Published - 1 Mar 2023

ID: 28208044